Tony Chachere’s Creole Foods of Opelousas, Inc. — Bold Creole Seasoning
by Tony Chachere's Creole Foods of Opelousas, Inc.MRT 176 Panel Triggers Identified
Clinical Product Assessment
Tony Chachere’s Creole Foods of Opelousas, Inc. manufactures this product, which has been analyzed against the full MRT 176 panel — comprising 149 foods and 27 chemical additives — to identify potential immune-mediated sensitivities.
MRT Safety Assessment
This assessment identified 3 distinct MRT-tested substances: Chili Pepper (found in red pepper and chili powder), Black Pepper, and Garlic. The presence of ‘spices’ constitutes an unknown variable that may contain additional tested substances. Due to the presence of 3 or more triggers, this product is classified as high risk and should only be used under the guidance of a practitioner during the maintenance phase.
Risk Summary
- Risk Classification: High Risk
- MRT Triggers Identified: 3
- Safe Ingredients: 2
- Unknown/Ambiguous: 1 (spices)
- LEAP Phase Compatibility: Phase 3 — Practitioner Guided
Flagged Ingredient Mapping
The following ingredients were identified as matching substances on the MRT 176 panel:
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| red pepper | Chili Pepper | Direct Match |
| black pepper | Black Pepper | Direct Match |
| chili pepper | Chili Pepper | Direct Match |
| spices | UNKNOWN | Potential Trigger |
| garlic powder | Garlic | Direct Match |
| garlic | Garlic | Direct Match |
Unknown / Ambiguous Ingredients
The following ingredients could not be definitively mapped to the MRT 176 panel: spices. Patients should treat these as potential triggers until MRT testing confirms safety.
LEAP Protocol Guidance
With 3 MRT-tested substances identified, this product is not recommended during Phase 1 or Phase 2. Phase 3 (Maintenance) patients should consult their Certified LEAP Therapist.
UPC Code: 071998001515
Assessment Methodology
This assessment was generated using Wellbloom’s automated clinical analysis pipeline. Each ingredient was cross-referenced against the complete MRT 176 panel — including 149 food antigens and 27 chemical additives.
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
Chili pepper (Capsicum) is tested on the MRT panel. It appears in hot sauces, spice blends, seasoned meats, and many Mexican, Asian, and Indian-cuisine-inspired processed foods.
Black pepper (Piper nigrum) is tested on the MRT panel. One of the most ubiquitous spices worldwide — found in virtually every seasoned or prepared food. Often hidden under "spices" on labels.
Garlic is an MRT-tested substance found in seasoning blends, sauces, and many processed foods. Often listed as "garlic powder," "dehydrated garlic," or hidden in "spices" or "natural flavors."
What This Means For Your Diet
With 3 identified triggers, this product has a high concentration of MRT-tested substances. The probability that at least one of these triggers is reactive on your personal panel is statistically significant.
This product is not recommended during Phase 1 (Elimination) or Phase 2 (Reintroduction). It may only be considered during Phase 3 (Maintenance) after your Certified LEAP Therapist has confirmed that all 3 substances scored Green on your individual MRT results.
Products with 3 or more MRT panel triggers require individualized evaluation. Do not attempt to self-assess — your CLT has the clinical training to weigh multiple reactive substances and potential cross-reactivity.
More from Tony Chachere's Creole Foods of Opelousas, Inc.
Tony Chachere’s Creole Foods of Opelousas, Inc. — CREOLE SEASONING
High RiskTony Chachere’s Creole Foods of Opelousas, Inc. — Creole Sasoning
High RiskTony Chachere’s Creole Foods of Opelousas, Inc. — Injectable Marinade
High RiskTony Chachere’s Creole Foods of Opelousas, Inc. — Crawfish & Crab Boil Seasoning, Crawfish & Crab
About This Assessment
This safety assessment was generated by cross-referencing the USDA FoodData Central ingredient record for this product against the 176 substances tested on the Mediator Release Test (MRT) panel. Clinical notes are produced with AI assistance using the matched ingredient data and reviewed by Kerry Watson, NTP, RWP for accuracy against published LEAP ImmunoCalm® protocol guidelines. Risk classifications are based on the number and type of MRT-tested substances identified. This information is for educational purposes only and is not medical advice — always consult your Certified LEAP Therapist before making dietary changes.
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners